As mentioned earlier, cardiovascular pathologies such as cardiac hypertrophy and associated myocardial matrix remodeling are epigenetically regulated where acetyltransferase p300 plays a pivotal role in disease development and progression. This evidence concerns the gene EP300 and cardiac hypertrophy.